Fig. 2.
Change in fasting plasma glucose concentration after treatment with imatinib in subjects with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.